Indoco Remedies' Goa facility receives Establishment Inspection Report from USFDA

Indoco Remedies announced today that it has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for their sterile facility (Plant II) and solid dosages facility (Plant III) at Verna, Goa. The inspection was held from 27 May, 2019 to 4 June, 2019, where the Company had received 4 observations (483s).

Powered by Capital Market - Live News